Physician profile
Lora Setterlund
NPI 1851901300
$1,763.53
in general payments reported to CMS, 2019-2025
17 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $415 · 2023: $619 · 2024: $277 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,231.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $250.11 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Sumitomo Pharma America, INC. | $238.97 | 2023-2025 | Myfembree |
| Abbvie INC. | $233.77 | 2022-2024 | |
| Exeltis, USA INC. | $200.68 | 2022-2025 | Slynd, Solosec |
| Mayne Pharma Commercial LLC | $193.77 | 2022-2024 | |
| Davol INC. | $171.40 | 2023 | Arista Ah Flexitip |
| Myovant Sciences INC. | $113.74 | 2021-2022 | |
| Galderma Laboratories, L.P. | $72.38 | 2025 | Dysport |
| Organon LLC | $70.10 | 2022-2025 | Nexplanon |
| Agile Therapeutics, INC. | $40.63 | 2023 | Twirla |
| Lupin INC. | $39.19 | 2021 | |
| Pfizer INC. | $35.36 | 2021-2022 | |
| Carl Zeiss Meditec USA, INC. | $33.81 | 2021 | |
| Medtronic, INC. | $23.40 | 2022 | |
| Currax Pharmaceuticals LLC | $16.52 | 2023 | Contrave |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $14.93 | 2023 | Balcoltra |
| Ascend Therapeutics US, LLC | $14.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Setterlund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.